Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × Everolimus × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Carcinoma, Renal Cell 6 Neuroendocrine Tumors 5 Neoplasm Metastasis 4 Tuberous Sclerosis 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Thyroid cancer, Hurthle cell 1 Thymus Neoplasms 1 Seizures 1 Recurrence 1 Pheochromocytoma 1 Phase IB 1 Paraganglioma 1 Nevus 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Meningioma 1 Lymphoma 1 Lymphangioma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hereditary leiomyomatosis and renal cell cancer 1

Interventions

Cyclophosphamide 3 fludarabine 2 Temozolomide 2 ibrutinib 1 gallium Ga 68 dotatate 1 Standard of Care 1 Radiotherapy 1 Etoposide 1 Eflornithine 1 Drug Therapy 1 CLR1404 1 Blood Specimen Collection 1 1-methyltryptophan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡